April 25, 2012, the company's listing through the Securities and Futures Commission Issue Review Committee review, the official release of the prospectus, landing on the GEM....
Changchun DIRUI Medical Technology Basic Information Basic Condition Company Name Changchun DIRUI Medical Technology Total Share Capital Before Issue 4600.00 Million Shares Total Share Capital After Issue 6134.00 Million Shares Number of Shares to be Issued 1534.00 Million Shares 25.01 % of Total Share Capital After Issue Related Announcements Changchun DIRUI Medical Technology Co. Financial indicators (as of December 31, 2011) Earnings per share 1.66 Net assets per share before issuance RMB5.47 per share Cash flow per share 0.85 Return on net assets 35.75% Underwriter and profit distribution Underwriting mode Underwriting method Balance underwriting Members of the Board of Examiners Wang Xiuping Wang Wang Guohai Ren Peng Li Tongyun Chen Jingru Kang JiYan Tan Hongxu Profit distribution Prior to the completion of the Offering Undistributed profits prior to the completion of the offering will be enjoyed by both new and existing shareholders in proportion to their shareholdings after the offering***. Main Business R&D, production and sales of medical testing instruments for urine, urine sediment, biochemistry, blood cells, etc. as well as supporting reagents for test strips (including calibrators, quality control solutions, etc.). Projects for which proceeds will be used No. Project name Investment amount (RMB) 1 Scale production project with annual output of 6,000 sets of fully automated clinical testing equipment and 90,000 boxes of auxiliary reagents 24,000 2 Construction project of R&D engineering center 13,000 3 Construction project of marketing network center 5,000 Total 42,000 Changchun Direxion Medical Science and Technology- -Financial Indicators of the Last Three Years Financial Indicators/Time 2011 2010 2009 Total Assets (RMB 100 million) 3859 2.324 1.701 Net Assets (RMB 100 million) 2.516 1.753 0.974 Minority Interest (RMB 100 million) 0.0425 Operating Revenues (RMB 100 million) 358,066 2.3119 1.7565 Net profit (RMB) 0.7631 0.6023 0.1891 Capital surplus (RMB) 0.9792 0.9792 0.0146 Undistributed profit (RMB) 0.9694 0.2824 0.5237 Basic earnings per share (RMB) 1.66 1.38 0.62 Diluted earnings per share (RMB) 1.66 1.38 0.62 Cash flow per share (RMB) 0.85 0.3 0.13 Return on net assets (%) 35.75 49.27 22.31 Major shareholders of Changchun Direxion Medical Technology No. Name of shareholders Number of shares held Percentage of total share capital 1 Ruifa Investment 33,000,000 71.74 2 Song Yong 5,308,600 11.54 3 Fosun Pharmaceutical 2,970,000 6.46 4 Song Jie 2,413,000 5.25 5 Gu Xiaofeng 1,930,400 4.20 6 Zhang Lichong 50,000 0.11 7 Yu Mingxin 50,000 0.11 8 Zhong Weiyu 50,000 0.11 9 Yu Tongle 30,000 0.07 10 Wang Bo 25,000 0.05